The Value of Calprotectin in Inflammatory Bowel Disease Monitoring - Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gut, which presents with periods of inflammatory activity (flares) and quiescent phases (remission) as can be seen in many chronic diseases. IBD includes several different diseases; the two most important ones are Ulcerative Colitis (UC), with inflammation localized mostly in the colon, and Crohn’s Disease (CD)
Validation of a Care Pathway for the Use of Faecal Calprotectin in Monitoring Patients with Crohn’s Disease - New BÜHLMANN fCAL® ELISA Citation: The team around James Turvill has proposed a highly useful care pathway for monitoring Crohn’s Disease patients. The care pathway offers a very high positive predictive value for the detection of patients with potential flare-ups of their disease while safely identifying those patients in which the therapy could be stepped down. Turvill J, Rook L, Rawle




DDW 2017

Date: 6 – 9 May 2017
Place: Chicago, IL, USA

Digestive Disease Week 2017. Visit us at booth #1925.


Date: 10 – 13 May 2017
Place: Prague, Czech Republic

50th Annual Meeting of the ESPGHAN


Date: 2 – 4 June 2017
Place: São Paulo, Brazil

IX SIMADII 2017 – Simpósio Internacional Bianual de DII

ÖGGH 2017

Date: 8 – 10 June 2017
Place: Linz, Austria

50. Jahrestagung & 28. Fortbildungskurs der ÖGGH